Ursula Storb, MD
Gene Expression

Professor, Molecular Genetics and Cell Biology, Committee on Genetics, Genomics & Systems Biology,
Committee on Cancer Biology, Committee on Immunology, Committee on Development, Regeneration & Stem Cell Biology

Universitaet Freiburg, Germany, M.D.


Research Summary

Gene expression is controlled by activation and repression. Repression can be caused by methylation of cytosine in the sequence 5'CpG3'. 70% of CGs are methylated in mammals. Preventing DNA methylation is embryonic lethal because it results in uncontrolled gene activation. Very little is known about how methylation is targeted. The methylation modifier gene, Ssm1, discovered by our laboratory, is a candidate for encoding such a novel targeting function. When a transgene, HRD, comes under the influence of Ssm1, it is highly methylated at CGs and not expressed. Ssm1 acts early in embryonic development. It seems to direct methyl-transferases to its target genes. Only after DNA methylation does the target gene adopt an inactive chromatin state and cease to be transcribed. We have mapped Ssm1 to a small interval in the mouse genome and have used positional cloning to identify the Ssm1 gene. Ssm1 encodes a KRAB-ZincFinger protein. We postulate that the Zinc fingers bind DNA sequences the embryo needs to inactivate and that the KRAB domain interacts with other proteins that cause methylation of the marked DNA sequences. The characterization of Ssm1 and the determination of its endogenous targets and effects throughout development are of major importance. It will help to understand how genes are targeted for silencing in normal development and cancer.

Another project is the somatic hypermutation (SHM) of immunoglobulin genes that encode antibodies for immunity. Antibodies are produced by B lymphocytes. When these cells encounter a foreign substance, such as bacteria or viruses, they undergo a very high rate of SHM of the expressed antibody genes. SHM is initiated by a cytidine deaminase changing cytosines into uracils. In other genes, such uracils are repaired by base excision repair. However, in antibody genes during SHM, error-prone DNA polymerases introduce more errors into all four bases (A, C, G, T). In this fashion, the affinity of the antibodies vastly increases, aiding the destruction of infectious agents or cancer cells. The molecular details of the mutation mechanism, including transcription, error prone DNA repair, and the role of chromatin are a major focus of our laboratory.


Under the control of the modifier Ssm1, the HRD transgene undergoes strain-specific DNA methylation.
Bisulfite analysis shows that CpG dinucleotides are almost completely methylated (red marks) in every transgene sequence in adult B6 (black mouse) but very little in D2 (beige mouse). Mice of the D2 strain express the transgene throughout life. B6 early embryos express the transgene, but starting around day 6 of embryogenesis, B6 mice cease expression when CpGs are completely methylated and inactivating chromatin changes have taken place.


Selected Publications

Kodgire, P., Mukkawar, P., North, J.A., Poirier, M. G., and Storb, U. (2012) Nucleosome stability dramatically impacts the targeting of somatic hypermutation. Mol. Cell Biol., 32:2030-2040. (PubMed)

Ratnam, S., Bozek, G., Nicolae, D., and Storb, U. (2010). The pattern of somatic hypermutation of Ig genes is altered when p53 is inactivated. Mol. Immunol., 47:2611-2618. (PubMed)

Tanaka, A., Shen, H., Ratnam, S., and Storb, U. (2010). Attracting AID to targets of somatic hypermutation. J. Exp. Med., 207:405-415. (PubMed)

Storb, U., Shen, H., and Nicolae, D. (2009). Somatic hypermutation: Processivity of the cytosine deaminase AID and error-free repair of the resulting uracils. Cell Cycle, 8:3097-3101. (PubMed)

Shen, H.M., Poirier, M.G., Allen, M., North, J., Lal, R., Widom, J., and Storb, U. (2009). The activation induced cytidine deaminase (AID) efficiently targets DNA in nucleosomes, but only during transcription. J.Exp Med., 206:1057-71. (PubMed)

Longerich, S., Orelli, B., Martin, R., Bishop, D., and Storb, U. (2008). Brca1 in Ig gene conversion and somatic hypermutation. DNA Repair, 7: 253-266. (PubMed)

Longerich, S., Meira, S., Shaw, D. Samson, L., and Storb, U. (2007). Alkyladenine glycosylase (Aag) in somatic hypermutation and class switch recombination. DNA Repair, 6:1764-1773. (PubMed)

Shen H., Tanaka, A., Bozek, G., Nicolae, D., and Storb, U. (2006). Somatic hypermutation and class switch recombination in Msh6-/-Ung-/- double-knockout mice. J. Immunol., 177:5386-5392. (PubMed)

Shen, H., Ratnam, S., and Storb, U. (2005). Targeting of the activation-induced cytosine deaminase (AID) is strongly influenced by the sequence and structure of the targeted DNA. Mol. Cell. Biol., 25:10815-10821. (PubMed)

Longerich, S., Tanaka, A., Bozek, G., Nicolae, D. and Storb, U. (2005). The very 5' end and the constant region of Ig genes are spared from somatic mutation because AID does not access these regions. J. Exp. Med., 202:1443-1454. (PubMed)

Padjen, K., Ratnam, S., and Storb, U. (2005). DNA methylation precedes chromatin modifications under the influence of the strain-specfici modifier Ssm1. Mol. Cell. Biol., 25: 4782-4791. (PubMed)

Shen, H. M. and Storb, U. (2004). Activation-induced cytidine deaminase (AID) can target both DNA strands when the DNA is supercoiled. Proc. Natl. Acad. Sci. U S A, 101: 12997-13002. (PubMed)

Michael, N., Shen, H. M., Longerich, S., Kim, N., Longacre, A. and Storb, U. (2003). The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity, 19: 235-42. (PubMed)

Sun, T., Clark, M. R. and Storb, U. (2002). A point mutation in the constant region of Ig lambda1 prevents normal B cell development due to defective BCR signaling. Immunity, 16: 245-55. (PubMed)

Michael, N., Martin, T. E., Nicolae, D., Kim, N., Padjen, K., Zhan, P., Nguyen, H., Pinkert, C. and Storb, U. (2002). Effects of sequence and structure on the hypermutability of immunoglobulin genes. Immunity, 16: 123-34. (PubMed)


© 2013 Cell and Molecular Biology ® The University of Chicago
Molecular Biosciences Graduate Programs
University of Chicago
920 E. 58th St., Rm. 1105
Chicago, IL 60637
phone: 773/702-8037
fax: 773/702-3172

Maps & Directions

to MGCB home page